PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Gabriel N Hortobagyi Selected Research
Mastectomy (Mammectomy)
12/2006
African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy.
07/2006
Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer.
06/2005
Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
12/2004
Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
05/2004
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
07/2002
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
Articles by Research Topic
Disease
96
Breast Neoplasms (Breast Cancer)
10/2008 - 01/2002
22
Carcinoma (Carcinomatosis)
06/2007 - 05/2002
16
Neoplasms (Cancer)
06/2008 - 06/2002
6
Neoplasm Metastasis (Metastasis)
01/2008 - 08/2005
2
Residual Neoplasm
07/2007 - 10/2006
2
Lobular Carcinoma
12/2006 - 01/2005
2
Male Breast Neoplasms (Male Breast Cancer)
07/2006 - 06/2002
1
Obesity
09/2008
1
Pancreatic Neoplasms (Pancreatic Cancer)
09/2008
1
Osteonecrosis (Kienbock's Disease)
06/2008
1
Phyllodes Tumor (Cystosarcoma Phylloides)
11/2007
1
Heart Failure
09/2007
1
Inflammation
08/2007
1
Noninfiltrating Intraductal Carcinoma (DCIS)
07/2007
1
Ductal Carcinoma
12/2006
1
Vasculitis (Vasculitides)
07/2006
1
Death (Near-Death Experience)
03/2005
1
Pneumonia (Pneumonitis)
11/2004
1
Colitis
10/2004
1
Neutropenia
01/2003
1
Ovarian Neoplasms (Ovarian Cancer)
11/2002
1
Pathologic Constriction (Stenosis)
06/2002
Drug/Important Bio-Agent (IBA)
13
Paclitaxel (Taxol)
FDA Link
Generic
03/2008 - 05/2002
13
Doxorubicin (Adriamycin)
FDA Link
Generic
11/2007 - 01/2002
9
docetaxel (Taxotere)
FDA Link
06/2008 - 01/2002
7
trastuzumab (Herceptin)
FDA Link
01/2007 - 04/2002
7
Fluorouracil (Carac)
FDA Link
Generic
01/2007 - 01/2002
7
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2007 - 01/2002
6
Biological Markers (Surrogate Marker)
IBA
12/2006 - 06/2002
5
Estrogens (Estrogen)
FDA Link
10/2008 - 07/2003
4
Epidermal Growth Factor Receptor (EGF Receptor)
IBA
10/2007 - 06/2005
4
taxane
IBA
08/2007 - 02/2002
3
capecitabine (Xeloda)
FDA Link
08/2007 - 09/2003
3
Epirubicin (Ellence)
FDA Link
Generic
01/2007 - 06/2005
2
Diphosphonates
IBA
06/2008 - 05/2008
2
erlotinib (CP 358,774)
FDA Link
08/2007 - 06/2007
2
Hormones
IBA
05/2007 - 03/2005
2
tau Proteins (tau Protein)
IBA
04/2007 - 06/2005
2
Tamoxifen
FDA Link
Generic
07/2006 - 01/2002
2
gemcitabine
FDA Link
09/2003 - 05/2002
2
vinorelbine (Navelbine)
FDA Link
Generic
05/2002 - 01/2002
2
5-ethynyluracil (eniluracil)
IBA
05/2002 - 02/2002
1
Lysine (L-Lysine)
FDA Link
09/2008
1
Histones (Histone)
IBA
09/2008
1
lapatinib (GW572016)
FDA Link
07/2008
1
Cisplatin (Platino)
FDA Link
Generic
05/2008
1
Dacarbazine (DIC)
FDA Link
Generic
11/2007
1
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
10/2007
1
ixabepilone (BMS 247550)
FDA Link
08/2007
1
I-kappa B Kinase
IBA
08/2007
1
Cyclin-Dependent Kinase 2
IBA
08/2007
1
DNA (Deoxyribonucleic Acid)
IBA
12/2006
1
Cyclins
IBA
10/2006
1
Phosphotransferases (Kinase)
IBA
10/2006
1
temozolomide (Temodar)
FDA Link
09/2006
1
Aromatase (CYP19)
IBA
07/2006
1
Leuprolide (Lupron)
FDA Link
Generic
07/2006
1
Cytosine Deaminase
IBA
01/2006
1
Endostatins
IBA
01/2006
1
Transcription Factors (Transcription Factor)
IBA
12/2005
1
Paraffin
IBA
10/2005
1
albumin-bound paclitaxel
FDA Link
09/2005
1
tariquidar (XR9576)
IBA
08/2005
1
P-Glycoprotein
IBA
08/2005
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
05/2005
1
Carmustine (FIVB)
FDA Link
11/2004
1
Thiotepa (Triethylenethiophosphoramide)
FDA Link
Generic
11/2004
1
Taxoids
IBA
07/2004
1
Protein Kinases (Protein Kinase)
IBA
02/2004
1
Proteins (Proteins, Gene)
IBA
01/2004
1
fludarabine
IBA
11/2003
1
Melphalan (Alkeran)
FDA Link
11/2003
1
NF-kappa B (NF-kB)
IBA
11/2003
1
sulindac sulfone (exisulind)
IBA
09/2003
1
pegylated liposomal doxorubicin
IBA
09/2003
1
DX 8951 (DX 8951f)
IBA
09/2003
1
Filgrastim (Neupogen)
FDA Link
07/2003
1
RNA (Ribonucleic Acid)
IBA
06/2003
1
bexarotene (LGD1069)
FDA Link
03/2003
1
Estrogen Receptors
IBA
03/2003
1
Cyclin E
IBA
11/2002
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
11/2002
1
Luteinizing Hormone (Lutropin)
FDA Link
Generic
11/2002
1
annamycin
IBA
07/2002
1
anastrozole (Arimidex)
FDA Link
06/2002
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2002
Therapy/Procedure
55
Drug Therapy (Chemotherapy)
09/2008 - 06/2002
9
Adjuvant Chemotherapy
10/2008 - 05/2002
6
Mastectomy (Mammectomy)
12/2006 - 07/2002
5
Neoadjuvant Therapy
03/2008 - 06/2005
2
Adjuvant Radiotherapy
10/2005 - 03/2005
1
Biological Therapy
05/2007
1
Hematopoietic Stem Cell Transplantation
11/2004
1
Aftercare (After-Treatment)
02/2004
1
Stem Cell Transplantation
11/2003
1
Estrogen Replacement Therapy
11/2002